Related Experiment Video
Updated: May 2, 2026

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Crosstalk between contact hypersensitivity reaction and antidepressant drugs
Katarzyna Curzytek1, Marta Kubera, Marian Szczepanik
1Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland. kubera@if-pan.krakow.pl.
Abstract:
Allergic contact dermatitis is a delayed-type hypersensitivity reaction mediated by hapten-specific T cells. Many cell types, inflammatory mediators and cytokines are involved in this reaction. Contact hypersensitivity is a self-limited reaction and can be regulated at different levels. Because it is known that disturbances in the immune system underpin the onset of depression and that antidepressant drugs have immunomodulatory effects, it can be hypothesized that antidepressants may have some efficacy in the treatment of contact hypersensitivity. There are some reports on the effectiveness of antidepressants in the inhibition of cutaneous sensitization in mice, and the aim of this narrative review is to assess the evidence for the effectiveness of antidepressant drugs in reducing the recurrence of contact hypersensitivity reactions.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Allergic Drug Reactions
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Allergic Reactions: Anaphylaxis
Cross-reactivity
Antidepressant Drugs: Overview

